K033470 is an FDA 510(k) clearance for the SIMULIX EVOLUTION. Classified as System, Simulation, Radiation Therapy (product code KPQ), Class II - Special Controls.
Submitted by Nucletron Corporation (Columbia, US). The FDA issued a Cleared decision on February 4, 2004 after a review of 93 days - within the typical 510(k) review window.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5840 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.